• Updated

FRIDAY, May 2, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called "Generation Gold Standard" to develop next-generation, universal vaccines using a beta-propiolactone (BPL)-inactivated, whole-virus platform.